Remarkably, we found that whereas these drugs alone have limited effect, the combination treatment induced a significant increase in apoptosis in PIK3CA mutant HNSCC cell line, Detroit 562, but not in the HRAS mutant HNSCC cells UM-SCC-17B (Figure 2C). Here, HRAS is linked to head and neck squamous cell carcinoma.